CANNABIDIOL | N210365 | JAZZ PHARMACEUTICALS RESEARCH UK LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al 1 patentANDA 217508, 217699, 215865, 217522, 217871, 217977, 217930, 217994, 217911, 217910cannabidiol | D.N.J. | 2023-07-21 | Terminated 2025-02-06 | — |
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al 25 patentsANDA 217508, 217699, 215865, 217522, 217871, 217977, 217930, 217994, 217911, 217910cannabidiol | D.N.J. | 2023-01-03 | Terminated 2025-02-06 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Ascend Laboratories, LLC FDA-2018-P-4590 Ascend Laboratories, LLC filed this citizen petition requesting that the FDA/DEA assign Schedule V classification to cannabidiol oral solution 100 mg/mL manufactured synthetically, citing that synthetic CBD would have reduced tetrahydrocannabinol content compared to the naturally derived reference l | 505(q) | 2018-12-03 | Open | Ascend Laboratories |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9949937 | Jun 17, 2035 | — | — | — | — | |
| 9956183 | Jun 17, 2035 | — | — | — | — | |
| 9956184 | Jun 17, 2035 | — | — | — | — | |
| 9956185 | Jun 17, 2035 | — | — | — | — | |
| 9956186 | Jun 17, 2035 | — | — | — | — | |
| 10092525 | Jun 17, 2035 | — | — | — | — | |
| 10111840 | Jun 17, 2035 | — | — | — | — | |
| 10137095 | Jun 17, 2035 | — | — | — | — | |
| 10603288 | Jun 17, 2035 | — | — | — | — | |
| 10709671 | Jun 17, 2035 | — | — | — | — | |
| 10709673 | Jun 17, 2035 | — | — | Yes | — | — |
| 10709674 | Jun 17, 2035 | — | — | — | — | |
| 10849860 | Jun 17, 2035 | — | — | — | — | |
| 10918608 | Oct 13, 2035 | — | — | — | — | |
| 10966939 | Jun 17, 2035 | — | — | Yes | — | |
| 11065209 | Oct 13, 2035 | — | — | — | — | |
| 11096905 | Oct 13, 2035 | — | Yes | Yes | — | |
| 11154516 | Jun 17, 2035 | — | — | — | — | |
| 11160795 | Mar 1, 2041 | — | — | — | — | |
| 11207292 | Apr 26, 2039 | — | Yes | — | — | |
| 11311498 | Jun 17, 2035 | — | — | — | — | |
| 11357741 | Jun 17, 2035 | — | — | — | — | |
| 11400055 | Oct 13, 2035 | — | — | — | — | |
| 11406623 | Mar 1, 2041 | — | — | — | — | |
| 11446258 | Jun 17, 2035 | — | — | — | — | |
| 11633369 | Jun 17, 2035 | — | — | Yes | — | |
| 11701330 | Jun 17, 2035 | — | — | — | — | |
| 11766411 | Jun 17, 2035 | — | — | — | — | |
| 11865102 | Apr 26, 2039 | — | Yes | Yes | — | |
| 11963937 | Jun 17, 2035 | — | — | — | — | |
| 12064399 | Jun 17, 2035 | — | — | — | — | |
| 12102619 | Mar 1, 2041 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| M-270 | Oct 20, 2026 | < 1 year |
| ODE-326 | Jul 31, 2027 | Active |
| ODE-332 | Jul 31, 2027 | Active |